Realcan Pharmaceutical Group Co (SZSE:002589) Ending Cash Position : ¥603 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Ending Cash Position?

Realcan Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥603 Mil.

Realcan Pharmaceutical Group Co's quarterly Ending Cash Position increased from Sep. 2023 (¥432 Mil) to Dec. 2023 (¥472 Mil) and increased from Dec. 2023 (¥472 Mil) to Mar. 2024 (¥603 Mil).

Realcan Pharmaceutical Group Co's annual Ending Cash Position declined from Dec. 2021 (¥836 Mil) to Dec. 2022 (¥487 Mil) and declined from Dec. 2022 (¥487 Mil) to Dec. 2023 (¥472 Mil).

Realcan Pharmaceutical Group Co Ending Cash Position Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Ending Cash Position Chart

Realcan Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,642.06

1,027.21

836.23

487.14

471.94

Realcan Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															868.43	895.11	431.55	471.94	602.75

Realcan Pharmaceutical Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Realcan Pharmaceutical Group Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	487.143	+	-15.201
	=	472

Realcan Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	471.942	+	130.806
	=	603

Realcan Pharmaceutical Group Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004

Website

http://www.realcan.cn

Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines